Persist AI is a TechBio services platform that combines AI/ML models, a high-throughput robotic Cloud Lab, and formulation scientists to accelerate pharmaceutical drug product formulation development and CMC activities by enabling remote experiment design, automated execution, and delivery of experimental datasets through a web portal.
Published Jul 31, 2026
Vendor materials include an attribution-style endorsement from an industry contact referencing Persist’s high-throughput formulation screening and AI-driven predictions. This is a vendor-selected testimonial and should be validated via direct reference checks.
Searches did not identify clear, high-signal Reddit or Hacker News threads about Persist AI's Cloud Lab or service quality in the reviewed results.
Company and press materials claim timeline reductions and high-throughput testing capacity. These are vendor statements and press-derived claims; buyers should request customer references and project postmortems for independent validation.
Company materials state reductions in labor, cost, and timelines. These statements lack publicly disclosed benchmarking methodology (baseline assumptions, project types, and cost accounting) and should be treated as directional until validated in a pilot or reference engagement.
Get a comprehensive analysis of Persist AI including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Persist AI is a biopharma formulation/robotic lab services company rather than a mainstream SaaS product listed on general review platforms such as G2 or Capterra. Searches for similarly named products commonly return unrelated entities. Those reviews are not attributable to Persist AI and should not be used to evaluate this company.
As a result:
Press coverage and vendor announcements describe an engagement in which the Cloud Lab tested a large number of LAI formulations over a short timeframe and identified an optimal recipe more rapidly than typical multi-month to year-long cycles.
Critical evaluation: the reported high-throughput outcomes appear to be derived from company-provided information and lack publicly available methodological detail (experiment controls, success criteria, assay comparability, and statistical design). Buyers should request the experimental design (DoE), release-testing methods, reproducibility metrics, the definition of "optimal" in QTPP/QbD terms, stability data (accelerated and long-term), and evidence of successful scale-up and tech transfer to GMP manufacturing before relying on such results.
Persist AI is a TechBio services platform that combines AI/ML models, a high-throughput robotic laboratory ("Cloud Lab"), and formulation scientists to accelerate pharmaceutical drug product formulation development, with a particular emphasis on long-acting injectable (LAI) / extended-release formulations (e.g., microspheres) and related CMC activities. The platform is designed to shorten formulation screening and iteration cycles by enabling customers to design experiments remotely while Persist executes them in an automated lab and returns datasets/results through a web portal.
Key components include:
(Primary product descriptions and service details are presented on Persist’s website and Cloud Lab pages.)